Announcement under Regulation 30 (LODR)-Credit Rating 9 Oct - CARE reaffirms A+/A1 ratings for SAMHI and subsidiaries’ bank facilities.
Source: Bse
Consumer stocks · Micro cap · NSE
Samhi Hotels owns and manages 31 business hotels (4,899 rooms) and has a pipeline of 7 new big-box hotels (1,669 rooms) in key Indian business districts. It also operates an asset-light leisure platform, RARE India, with 75 hotels (1,046 rooms) across India, Nepal, and Bhutan, leveraging global partnerships.
full bear SMA stack · SMA20 -3.8% / mo · MACD + · sector -3.7pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Strong fundamentals, management evidence is still limited to a financial-only Trust Lite signal, but price trend argues for patience. Suitable for staggered entry or watchlist confirmation rather than aggressive buying.
Strong U-Score but weak trend: timing is not confirming the thesis.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +12.1% · PAT +31.6% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
margin compression · Rev +12% YoY · PAT +32% YoY · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹305 Cr | +12.1% | -11.6% |
| EBITDA | ₹98 Cr | +8.9% | -12.5% |
| Operating margin | 32.0% | -100 bps | +0 bps |
| PAT | ₹25 Cr | +31.6% | -93.7% |
| PAT margin | 8.2% | +121 bps | -10745 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term trend down. RSI 42. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 83 · legacy U-Score band DEEP VALUE · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Consumer franchises can deserve higher multiples, but only when growth quality supports them.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Consumer — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q1 FY27 comparable revenue grew 10.8% YoY and comparable EBITDA 12.1% YoY, driven by strong domestic demand and 79.3% occupancy. Reported figures were impacted by one-time items and GST changes, leading to a -4.1% YoY reported EBITDA decline.
The company demonstrated resilient comparable growth in Q1 FY27, with strong occupancy and RevPAR, despite external headwinds. The strategic shift towards upscale inventory and the asset-light RARE India platform offer future margin and growth potential, though reported numbers were impacted by one-off items and GST.
Latest issuer-disclosed distribution across 3 reported categories.
Strong growth pipeline of 7 new big-box hotels in key commercial districts across India, with 1,669 rooms.
On-going rebranding/renovations to increase upscale share from ~41% to ~60% by FY2030, boosting overall revenue per key.
Asset-light, scalable, and unique platform with 75 hotels, leveraging a pending partnership with Marriott for distribution.
Plans to invest capital to acquire select RARE Hotels where incumbent owners want to exit, offering exceptional returns due to low entry price.
170 rooms, opening Q4 FY27, currently under fit-out.
220 new rooms, opening FY30, currently under construction.
700 rooms (350 Westin, 350 Fairfield), opening FY31, currently in design phase.
162 rooms, opening FY30, currently in design phase.
Domestic travelers now constitute 81% of total room nights sold in Q1 FY27, up from 78% YoY, providing resilience against geopolitical instability.
Office leasing momentum remains strong, especially in GCCs, led by Bangalore, Hyderabad, and Pune, accounting for 65%+ of leasing activity.
Pending partnership with Marriott will unlock phenomenal value for RARE’s hotel partners and for SAMHI as a shareholder through global distribution.
Middle East conflict impacted international business and airline passenger growth, affecting overall demand.
Shift from 12% with ITC to 5% without input credit compressed reported EBITDA growth by ~₹92mn for the quarter.
Delay in approvals for 22 completed apartments at Hyatt Regency Pune is causing loss of revenue in a strong market.
Ongoing macro-economic situation and large dependence on gulf carriers for international traffic impacted air passenger trends.
GST change from 12% with ITC to 5% without input credit compressed reported EBITDA growth.
Delay in approvals for Hyatt Regency Pune apartments causing loss of revenue, indicating potential for project delays.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
The hotel business often experiences seasonality, making year-over-year comparisons more relevant for assessing underlying performance trends and growth. The presentation itself emphasizes YoY comparable growth.
Comparable Revenue growth of +10.8% YoY.
Consol. EBITDA growth of +12.1% YoY Comparable.
Occupancy level ~79.3% (up from ~74.2% Q1-FY26).
Same-store RevPAR ₹5,219, a +9.6% YoY growth.
The ongoing growth pipeline within our core portfolio and the progress in RARE India gives us a formidable path to growth.
Our balance sheet is healthy; we are steadfast on making it even stronger and an anchor stone for our future growth.
With most new openings in the upscale segment, we expect our EBITDA margins to improve to ~40%.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| RARE India - Marriott Integration | 40+ hotels agreed to Marriott Outdoor Collection; 15 pilot properties shortlisted. | Successful integration of pilot properties with Marriott in H2 FY27. |
| Hyatt Regency Pune Approvals | 22 apartments fully completed; delay in approvals. | Timely receipt of approvals and commencement of revenue generation from these apartments. |
| Upscale Segment Share | 41% of total income in Q1 FY27. | Progress towards increasing upscale share to ~60% by FY2030 through new openings and rebranding. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 88th percentile of the scored universe and 92nd percentile within Consumer. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Consumer: 92nd pctile, median 66 · Micro: 79th pctile, median 73
57 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse